Henry T Gaud

Person

Evanston, IL, US

People

Patents Grantslast 30 patents

Information Patent Grant
Synthesis of diaryl pyrazoles
- Patent number 7,759,497
- Issue date Jul 20, 2010
- Pfizer Inc.
- Leo J. Letendre
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Synthesis of diaryl pyrazoles
- Patent number 7,141,678
- Issue date Nov 28, 2006
- Pharmacia Corporation
- Leo J. Letendre
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline form of 4-[5-methyl-3-phenylisoxazol-4-yl] benzenesulfo...
- Patent number 7,135,489
- Issue date Nov 14, 2006
- G. D. Searle & Co.
- John J Talley
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline form of 4-[5-methyl-3-phenylisoxazol-4-yl&#x000...
- Patent number 6,441,014
- Issue date Aug 27, 2002
- G. D. Searle & Co.
- John J Talley
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Eplerenone Drug Substance Having High Phase Purity
- Publication number 20090149431
- Publication date Jun 11, 2009
- Kathleen P. Barton
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE FORM OF 4-[5-METHYL-3-PHENYLISOXAZOL-4-YL] BENZENESULFO...
- Publication number 20070072921
- Publication date Mar 29, 2007
- John J. Talley
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Eplerenone crystalline form exhibiting enhanced dissolution rate
- Publication number 20050267302
- Publication date Dec 1, 2005
- G.D. Searle & Co.
- Kathleen P. Barton
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Eplerenone drug substance having high phase purity
- Publication number 20050261261
- Publication date Nov 24, 2005
- Pharmacia Corporation
- Kathleen P. Barton
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Eplerenone crystal form exhibiting enhanced dissolution rate
- Publication number 20050159594
- Publication date Jul 21, 2005
- Pharmacia Corporation
- Kathleen P. Barton
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Synthesis of diaryl pyrazoles
- Publication number 20040024225
- Publication date Feb 5, 2004
- Pharmacia Corporation
- Leo J. Letendre
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Eplerenone drug substance having high phase purity
- Publication number 20030083493
- Publication date May 1, 2003
- Kathleen P. Barton
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Crystalline form of 4-[5-methyl-3-phenylisoxazol-4-YL] benzenesulfo...
- Publication number 20030004200
- Publication date Jan 2, 2003
- G.D. Searle & Co.
- John J. Talley
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Eplerenone crystalline form
- Publication number 20020045746
- Publication date Apr 18, 2002
- Kathleen P. Barton
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Eplerenone crystalline form exhibiting enhanced dissolution rate
- Publication number 20020038021
- Publication date Mar 28, 2002
- Kathleen P. Barton
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Crystalline form of 4- [ 5-methyl-3-phenylisoxazol-4-yl ] benzenesu...
- Publication number 20010003752
- Publication date Jun 14, 2001
- G.D. Searle & Co.
- John J. Talley
- C07 - ORGANIC CHEMISTRY

Henry T Gaud

Person

Patents Grantslast 30 patents

Synthesis of diaryl pyrazoles

Synthesis of diaryl pyrazoles

Crystalline form of 4-[5-methyl-3-phenylisoxazol-4-yl] benzenesulfo...

Crystalline form of 4-&#x0005B;5-methyl-3-phenylisoxazol-4-yl&#x000...

Patents Applicationslast 30 patents

Eplerenone Drug Substance Having High Phase Purity

CRYSTALLINE FORM OF 4-[5-METHYL-3-PHENYLISOXAZOL-4-YL] BENZENESULFO...

Eplerenone crystalline form exhibiting enhanced dissolution rate

Eplerenone drug substance having high phase purity

Eplerenone crystal form exhibiting enhanced dissolution rate

Synthesis of diaryl pyrazoles

Eplerenone drug substance having high phase purity

Crystalline form of 4-[5-methyl-3-phenylisoxazol-4-YL] benzenesulfo...

Eplerenone crystalline form

Eplerenone crystalline form exhibiting enhanced dissolution rate

Crystalline form of 4- [ 5-methyl-3-phenylisoxazol-4-yl ] benzenesu...

Crystalline form of 4-[5-methyl-3-phenylisoxazol-4-yl&#x000...